{
    "Trade/Device Name(s)": [
        "ScanScope\u00ae XT System",
        "IHC HER2 Image Analysis application"
    ],
    "Submitter Information": "Aperio Technologies, Inc.",
    "510(k) Number": "K071128",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032113"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT"
    ],
    "Summary Letter Date": "April 20, 2007",
    "Summary Letter Received Date": "April 23, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "HER2/neu (c-erbB-2)"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded normal tissue",
        "Formalin-fixed, paraffin-embedded neoplastic tissue",
        "Breast cancer tissue"
    ],
    "Specimen Container(s)": [
        "Glass microscope slide"
    ],
    "Instrument(s)/Platform(s)": [
        "ScanScope\u00ae XT digital slide scanner",
        "Computer",
        "Color monitor",
        "Keyboard",
        "Spectrum\u2122 digital pathology information management software"
    ],
    "Method(s)/Technology(ies)": [
        "Automated digital slide scanning",
        "Image analysis",
        "Colorimetric pattern recognition",
        "Computer-assisted microscopy"
    ],
    "Methodologies": [
        "Digital pathology",
        "Semi-quantitative measurement",
        "Automated image analysis"
    ],
    "Submission Type(s)": [
        "System",
        "Accessory",
        "Software",
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Aperio ScanScope XT System, a digital pathology system and HER2 image analysis software for aiding pathologists in breast cancer assessment",
    "Indications for Use Summary": "Intended for in vitro diagnostic use to aid pathologists in the display, detection, counting, and classification of tissues and cells, and to assist in semi-quantitative measurement of HER2/neu in formalin-fixed, paraffin-embedded tissue as an accessory to Dako HercepTest in breast cancer assessment for HERCEPTIN (Trastuzumab) consideration",
    "fda_folder": "Hematology"
}